Marinomed Biotech AG has been listed on the Vienna Stock Exchange since 1 February 2019. The shares are listed in the Prime Market segment and included in the ATX Prime Index.
|Share class||No-par bearer shares|
|Nominal capital||EUR 1,260,000 (1,260,000 no-par value shares)|
|Issue price (IPO) on 1.2.2019||EUR 75.00|
|Market capitalization (at issue price)||EUR 97.4 Mio.|
For current price information please follow the link to the website of the Vienna Stock Exchange.
Erste Group (Vladimira Urbankova)
|Selected key financial figures|
|in EUR Mio.||2017||2016|
|Operating result (EBIT)||-1.64||-1.53|
|Loss for the year||-2.38||-1.97|
|Cash and cash equivalents per 31.12.||6.03||2.01|
|Balance sheet total per 31.12.||9.33||4.92|
|Net cash flow||4.02||-1.60|